Articles les plus consultés

jeudi 14 juin 2018

Global Healthcare Contract Research and Manufacturing Outsourcing Market to Post a CAGR of 12% | Technavio | Business Wire

Global Healthcare Contract Research and Manufacturing Outsourcing Market to Post a CAGR of 12% | Technavio | Business Wire: The global healthcare contract research and manufacturing outsourcing market is set to post a CAGR of almost 12% until 2022, according to Technavio.

DIAXONHIT DEVIENT EUROBIO SCIENTIFIC : Changement de nom adopté à l'Assemblée Générale Annuelle

DIAXONHIT DEVIENT EUROBIO SCIENTIFIC : Changement de nom adopté à l'Assemblée Générale Annuelle

Trillium Therapeutics Doses First Patient With TTI-622, Its Second Immune Checkpoint Inhibitor Targeting CD47

Trillium Therapeutics Doses First Patient With TTI-622, Its Second Immune Checkpoint Inhibitor Targeting CD47

Elite Pharmaceuticals, Inc. Announces Passing of Board Member Eugene Pfeifer

Elite Pharmaceuticals, Inc. Announces Passing of Board Member Eugene Pfeifer

mercredi 13 juin 2018

FDA Clears Gold Standard Diagnostics’ Borrelia burgdorferi IgG/IgM ELISA Assay | Business Wire

FDA Clears Gold Standard Diagnostics’ Borrelia burgdorferi IgG/IgM ELISA Assay | Business Wire: Gold Standard Diagnostics, Corp. today announced the U.S. Food and Drug Administration issued a 510(k) clearance for its Borrelia burgdorferi IgG/IgM

Global Disposable Blood Bag Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 11% - ResearchAndMarkets.com | Business Wire

Global Disposable Blood Bag Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 11% - ResearchAndMarkets.com | Business Wire: The

ExThera Medical gibt Abschluss von Studie zur Bewertung der Sicherheit des Blutfilters Seraph® 100 für die Registrierung der CE-Kennzeichnung bekannt | Business Wire

ExThera Medical gibt Abschluss von Studie zur Bewertung der Sicherheit des Blutfilters Seraph® 100 für die Registrierung der CE-Kennzeichnung bekannt | Business Wire: Die ExThera Medical Corporation, ein Entwickler von Therapien für die Entfernung von Bakterien und Viren aus dem Blut, hat heute den Abschluss ihrer S